Mathew Mitchell
Mathew Mitchell is a multifaceted innovator and entrepreneur. In addition to being a founding member and CTO of Organicin Scientific since its inception, he is a Fulbright research scholar, and M.D. Candidate. After his father survived pancreatic cancer by undergoing the Whipple procedure only to battle several multidrug-resistant infections, Mathew dedicated his career to fighting the antibiotic resistance crisis.
Equipped with a B.S. in Biochemistry & Molecular Biology and an M.S. in Physiology & Biophysics, Mathew has demonstrated high-impact research contributions through several peer-reviewed publications and patent applications. Apart from his deep biochemical and medical expertise, he is also the visionary and primary architect behind Organicin Scientific’s CinThesis machine learning platform for bacteriocin discovery.
Mathew has represented Organicin Scientific at numerous international conferences spanning several domains from agriculture and animal health to machine learning and medicine. Most notably, he participated in the FAO and XTC startup innovation awards in 2023 where he won the Better Environment award, and in 2024 where he spoke in the grand opening ceremony on financing and investing in agrifood systems.
-
![]()
Extreme Tech Challenge Founder Spotlight
This week in our Startup Spotlight blog series is our 2023 Winner, Better Environment Category, UN World Food Forum Startup Innovation Awards by XTC - Organicin Scientific!
-
![]()
WFF Startup Innovation Award Recipient
This third edition of the annual global startup competition was concluded with the live Finals pitch session held at the Food and Agriculture Organization of the United Nations (FAO) Headquarters during the 2023 World Food Forum flagship event.
-
![]()
PennHealthX - Clinic of The Future Award Recipient
The PennHealthX innovation program was founded at UPenn in 2013 and has grown into a fully funded program that provides medical students with opportunities to explore, experience, and contribute to innovation in health care.
-
![]()
The Microbiologist Opinion
The field of microbiology must adopt a perspective that views the human microbiome as a critical organ system, where disruption by non-targeted antibiotic activity equates to toxicity.
-
![]()
Nisin Inhibition of Gram Negative Bacteria
When compared to the mass literature showing nisin activity against Gram-positive bacteria, there are relatively few such studies with Gram-negative bacteria, and the strain numbers employed are often quite limited.
-
![]()
Organicin Human Health Fulbright Research
Organicin Scientific cofounder and CTO Mathew Mitchell awarded Fulbright research grant for investigating microbiome remodeling for noninfectious human health disease in Budapest
